AcharyaR.,
FryE.,
StuartD.,
FoxG.,
RolandsD.,
BrownF.1989; The three dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature 337:709–716
BlondelB.,
CrainicR.,
FichotO.,
DufraisseG.,
CandreaA.,
DiamondD.,
GirardM.,
HoraudF.1986; Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody binding site. Journal of Virology 57:81–90
CollenT.1991T Cell responses of cattle to foot-and-mouth disease virus PhD thesis CNAA/AFRC Institute for Animal Health, Pirbright Laboratory; Pirbright, UK.:
CollenT.,
PullenL.,
DoelT. R.1989; T Cell-dependent induction of antibody against foot-and-mouth disease virus in a mouse model. Journal of General Virology 70:395–403
CollenT.,
DiMarchiR.,
DoelT. R.1991; A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. Journal of Immunology 146:749–755
CraneM. A.,
JueC.,
MitchellM.,
LiptonH.,
KimB. S.1990; Detection of restricted predominant epitopes of Theiler’s murine encephalomyelitis virus capsid proteins expressed in the lgt11 system: differential patterns of antibody reactivity among different mouse strains. Journal of Neuroimmunology 27:173–186
CrowtherJ. R.,
FariasS.,
CarpenterW. C.,
SamuelA. R.1993; Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. Journal of General Virology 74:1547–1553
DiamondD. C.,
JamesonB. A.,
BoninJ.,
KoharaM.,
AbeS.,
ItohH.,
KomatsuT.,
AritaM.,
KugeS.,
NomotoA.,
OsterhausA. D. M. E.,
CrainicR.,
WimmerE.1985; Antigenic variation and resistance to neutralization in poliovirus type 1. Science 229:1090–1093
FilmanD. J.,
SyedR.,
ChowM.,
MacadamA. J.,
MinorP. D.,
HogleJ. M.1989; Structural factors that control conformation transitions and serotype specificity in type 3 poliovirus. EMBO Journal 8:1567–1579
FrancisM. J.,
FryC. M.,
RowlandsD. J.,
BrownF.,
BittleJ. L.,
HoughtenR. A.,
LernerR. A.1985; Immunological priming with synthetic peptides of foot-and-mouth disease virus. Journal of General Virology 66:2347–2354
GeretyS. J.,
KarpusW. J.,
CubbonA. R.,
GoswamiR. G.,
RundellM. K.,
PetersonJ. D.,
MillerS. D.1994; Class II-restricted T cell responses in Theiler’s murine encephalomyelitis virus-induced demyelinating disease, V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice. Journal of Immunology 152:908–918
GlassE. J.,
OliverR. A.,
CollenT.,
DoelT. R.,
DiMarchiR.,
SpoonerR. L.1991; MHC class II recognition of FMDV peptides by bovine T cells. Immunology 74:594–599
GrahamS.,
WangE. C. Y.,
JenkinsO.,
BorysiewiczL. K.1993; Analysis of the human T-cell response to picornaviruses: identification of T-cell epitopes close to B cell epitopes in poliovirus. Journal of Virology 67:1627–1637
GrantR. A.,
FilmanD. J.,
FujinamiR. S.,
IcenogleJ. P.,
HogleJ. M.1992; Three-dimensional structure of Theiler virus. Proceedings of the National Academy of Sciences, USA 89:2061–2065
HarmonS. A.,
BromanB.,
PowdrillT. F.,
JohnstonJ. M.,
EhrenfeldE.,
SummersD. F.1993; Localization of a priming epitope to the C-terminal portion of hepatitis A virus VP1. Journal of Infectious Diseases 167:990–992
HastingsG. Z.,
FrancisM. J.,
RowlandsD. J.,
ChainB. M.1993; Epitope analysis of the T cell response to a complex antigen: proliferative response to human rhinovirus capsids. European Journal of Immunology 23:2300–2305
HuberS. A.,
JobL. P.,
WoodruffJ. F.1980; Lysis of infected myofibers by coxsackievirus B-3-immune T lymphocytes. American Journal of Pathology 98:681–694
KatrakK.,
MahonB. P.,
MinorP. D.,
MillsK. H. G.1991; Cellular and humoral immune responses to poliovirus in mice: a role for helper T cells in heterotypic immunity to poliovirus. Journal of General Virology 72:1093–1098
KimB. S.,
ChoeY.-K.,
CraneW. A.,
JueC. R.1992; Identification and localization of a limited number of predominant conformation-independent antibody epitopes of Theiler’s murine encephalomyelitis virus. Immunology Letters 31:199–206
KitsonJ. D. A.,
McCahonD.,
BelshamG. J.1990; Sequence analysis of moclonal antibody resistant mutants of type O foot-and-mouth disease virus: evidence for the involvement of three surface exposed capsid proteins in four antigenic sites. Virology 179:26–34
KobasaD.,
MuirS.,
BittleJ. L.,
ScrabaD. G.1993; Mapping the T-cell determinants on the Mengo virion. IXth International Congress of Virology 238: abstract P31–27
LeclercC.,
DeriaudE.,
MimicV.,
van der WerfS.1991; Identification of a T cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1. Journal of Virology 65:711–718
LiQ.,
YafalA. G.,
LeeY. M.,
HogleJ.,
ChowM.1994; Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature. Journal of Virology 68:3965–3970
LindsleyM. D.,
ThiemannR.,
RodriguezM.1991; Cytotoxic T cells isolated from the central nervous system of mice infected with Theiler’s virus. Journal of Virology 65:6612–6620
LiuY.,
MuG.-F.,
LuH.,
GuF.-Z.1988; Characterization of VP1 as immunodominant antigen of enterovirus type 70 and antigenic analysis of virus strains by monoclonal antibodies. Chinese Medical Journal 101:20–24
LoganD.,
Abu-GhazalehR.,
BlakemoreW.,
CurryS.,
JacksonT.,
KingA.,
LeaS.,
LewisR.,
NewmanJ.,
ParryN.,
RowlandsD.,
StuartD.,
FryE.1993; Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 362:566–568
LuoM.,
RossmanM. G.,
PalmenbergA. C.1988; Prediction of three-dimensional models for foot-and-mouth disease virus and hepatitis A virus. Virology 166:503–514
LuoM.,
HeC.,
TothK. S.,
ZhangC. X.,
LiptonH. L.1992; Three-dimensional structure of Theiler murine encephalomyelitis virus (BeAn strain). Proceedings of the National Academy of Sciences, USA 89:2409–2413
McCahonD.,
CrowtherJ. R.,
BelshamG. J.,
KitsonJ. D. A.,
DuchesneM.,
HaveP.,
MeloenR. H.,
MorganD. O.,
De SimoneF.1989; Evidence for at least four antigenic sites on type 1 foot-and-mouth disease virus involved in neutralization: identification by single and multiple site monoclonal antibody-resistant mutants. Journal of General Virology 70:639–645
MahonB. P.,
KatrakK.,
MillsK. H. G.1992; Antigenic sequences of poliovirus recognised by T cells: serotype-specific epitopes on VP1 and VP3 and cross-reactive epitopes on VP4 defined by using CD4+ T cell clones. Journal of Virology 66:7012–7020
MinorP. D.,
EvansD. M. A.,
FergusonM.,
SchildG. C.,
WestropG.,
AlmondJ. W.1985; Principle and subsiduary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. Journal of General Virology 66:1159–1165
MinorP. D.,
FergusonM.,
EvansD. M. A.,
AlmondJ. W.,
IcenogleJ. P.1986; Antigenic structure of polioviruses of serotypes 1. 2 and 3. Journal of General Virology 67:1283–1291
MuirS.,
WeintraubJ. P.,
HogleJ.,
BittleJ. L.1991; Neutralizing antibody to Mengo virus, induced by synthetic peptides. Journal of General Virology 72:1087–1092
NainanO. V.,
BrintonM. A.,
MargolisH. S.1992; Identification of amino acids located in the antibody binding sites of hepatitis A virus. Virology 191:984–987
PageG. S.,
MosserA. G.,
HogleJ. M.,
FilmanD. J.,
RuekertR. R.,
ChowM.1988; Three dimensional structure of poliovirus serotype 1 neutralizing determinants. Journal of Virology 62:1781–1794
PalmenbergA. C.1989; Sequence alignments of picornaviral capsid proteins. In Molecular Aspects of Picornaviral Infection and Detection pp 211–241 Edited by
SemlerB. L.,
EhrenfeldE.
Washington, DC: American Society for Microbiology;
PevearD. C.,
LuoM.,
LiptonH. L.1988; Three-dimensional model of the capsid proteins of two biologically different Theiler virus strains: clustering of amino acid differences identifies possible locations of immunogenic sites on the virion. Proceedings of the National Academy of Sciences, USA 85:4496–4500
PfaffE.,
MullerH.,
HaasB.,
ThielH. J.1989; Molecular and immunological analysis of foot-and-mouth disease virus mutants. In Vaccines89 pp 449–455 Edited by
LernerR. A.,
GinsbergH.,
ChanockR. M.,
BrownF.
New York: Cold Spring Harbor Laboratory;
PingL.-H.,
LemonS. M.1992; Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies. Journal of Virology 66:2208–2216
PingL.-H.,
JansenR. W.,
StapletonJ. T.,
CohenJ. I.,
LemonS. M.1988; Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus. Proceedings of the National Academy of Sciences, USA 85:8281–8285
PrabhakarB. S.1988; Application of monoclonal antibodies to the study of coxsackieviruses. In Coxsackieviruses - A General Update pp 117–134 Edited by
BendinelliM.,
FriedmannH.
New York: Plenum Press;
ReimannB.-Y.,
ZellR.,
KandolfR.1991; Mapping of a neutralizing antigenic site of coxsackievirus B4 by construction of an antigen chimera. Journal of Virology 65:3475–3480
RossmanM. G.1989; The canyon hypothesis. Hiding the host cell receptor attachment site on the viral surface from immune surveillance. Journal of Biological Chemistry 264:14587–14590
RossmanM. G.,
ArnoldE.,
EriksonJ. W.,
FrankenbergerE. A.,
GriffithJ. P.,
HechtH. J.,
JohnsonJ. E.,
KamerG.,
LuoM.,
MosserA. G.,
RuekertR. R.,
SherryB.,
VriendG.1985; Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 317:145–153
SercarzE. E.,
LehmannP. V.,
AmetaniA.,
BenichouG.,
MillerA.,
MoudgilK.1993; Dominance and crypticity of T cell antigenic determinants. Annual Review of Immunology 11:729–766
SherryB.,
MosserA. G.,
ColonnoR. J.,
RuekertR. R.1986; Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus-14. Journal of Virology 57:246–257
SimonsJ.,
KutubuddinM.,
ChowM.1993; Characterization of poliovirus-specific T lymphocytes in the peripheral blood of Sabin-vaccinated humans. Journal of Virology 67:1262–1268
SmythM. C.,
TrudgettA.,
HoeyE. M.,
MartinS. J.,
BrownF.1992; Characterization of neutralizing antibodies to bovine enterovirus elicited by synthetic peptides. Archives of Virology 126:21–33
StapletonJ. T.,
LemonS. M.1987; Neutralization escape mutants define a dominant immunogenic neutralization site on hepatitis A virus. Journal of Virology 61:491–498
StaveJ. W.,
CardJ. L.,
MorganD. O.,
VakhariaV. N.1988; Neutralization sites of type Ol foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape virus variants. Virology 162:21–29
ThomasA. A. M.,
WoortmeuerR. J.,
PuukW.,
BartelingS. J.1988; Antigenic sites on foot-and-mouth disease virus type O10. Journal of Virology 62:2782–2789
VallbrachtA.,
MaierK.,
StierhofY. D.,
WiedmannK. H.,
FlehmingB.,
FleischerB.1989; Liver-derived cytotoxic T cells in hepatitis A virus infection. Journal of Infectious Diseases 160:209–217
WeigersK.,
UhligH.,
DernickR.1989; N-AglB of poliovirus type 1: a discontinuous epitope formed by two loops of VP1 containing residues 96-104 and 141–152. Virology 170:583–586
WeigersK. J.,
WetzK.,
DernickR.1990; Molecular basis for linkage of a continuous and discontinuous and neutralization epitope on the structural polypeptide VP2 of poliovirus type 1. Journal of Virology 64:1283–1289
XieQ.-C.,
McCahonD.,
CrowtherJ. R.,
BelshamG. J.,
McCulloughK. C.1987; Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites. Journal of General Virology 68:1637–1647
ZurbriggenA.,
FujinamiR. S.1989; A neutralization-resistant Theiler’s virus produces an altered disease pattern in the mouse CNS. Journal of Virology 63:1505–1513
ZurbriggenA.,
ThomasC.,
YamadaM.,
RoosR. P.,
FujinamiR. S.1991a; Direct evidence for a role for amino acid 101 of VP1 in central nervous system disease in Theiler’s murine encephalomyelitis virus. Journal of Virology 65:1929–1937
ZurbriggenA.,
YamadaM.,
ThomasC.,
FujinamiR. S.1991b; Restricted viral replication in the spinal cords of nude mice infected with a Theiler’s virus variant. Journal of Virology 65:1023–1030